Cambridge Epigenetix's Series B Round

Cambridge Epigenetix raised a round of funding on March 14, 2016.

Cambridge Epigenetix is commercializing a novel technology that pioneers quantitative single-base resolution sequencing of the methylated bases 5-hmC and 5-mC leading to substantially more accurate de…

Articles about Cambridge Epigenetix's Series B Round: